Hu, S., Xu-Monette, Z. Y., Balasubramanyam, A., Manyam, G. C., Visco, C., Tzankov, A., . . . Young, K. H. (2013). CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: A report from the International DLBCL Rituximab-CHOP Consortium Program Study. American Society of Hematology.
Dyfyniad Arddull ChicagoHu, Shimin, et al. CD30 Expression Defines a Novel Subgroup of Diffuse Large B-cell Lymphoma With Favorable Prognosis and Distinct Gene Expression Signature: A Report From the International DLBCL Rituximab-CHOP Consortium Program Study. American Society of Hematology, 2013.
Dyfyniad MLAHu, Shimin, et al. CD30 Expression Defines a Novel Subgroup of Diffuse Large B-cell Lymphoma With Favorable Prognosis and Distinct Gene Expression Signature: A Report From the International DLBCL Rituximab-CHOP Consortium Program Study. American Society of Hematology, 2013.